The epidermal growth factor receptor (EGFR) is known to be overexpressed in several cancer types, such as lung adenocarcinoma, head and neck squamous cell carcinoma, and colorectal carcinoma [45,46]. This evidence concerns the gene EGFR and colorectal carcinoma.